Resources
The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Biomarkers in Immuno-Oncology
Rules Based Medicine: Operational Procedures
Rules-Based Medicine (RBM), a Q2 Solutions Company, has spent over 20 years developing and optimizing multiplex immunoassays based on the Luminex xMAP® technology.
Biomarkers in Immuno-Oncology
NeoGenomics: Transforming Care for Cancer Patients
Comprehensive service overview for pharmaceutical partners
Biomarkers in Immuno-Oncology
SyncroPatch 384 For All Your Patch Clamp Needs
Unprecedented flexibility for HTS automated patch clamp.
Biomarkers in Immuno-Oncology
Nanion: Cell Analytics Brochure
Next level live-cell kinetic and phenotypic assays.
Biomarkers in Immuno-Oncology
AtlaZ: Quantitative Live-Cell Analytics
Welcome to the next level of live-cell analytics.
Biomarkers in Immuno-Oncology
Immune Cell-mediated Killing of A549 Cancer Target Cells in Real-time
Nanion Technologies GmbH, Munich. TUM, Munich
Therapeutic Modalities
Monitoring Cell – Attachment and Tightjunctions in the Same Assay
Nanion Technologies GmbH, Munich. University of Regensburg, Regensburg.
Therapeutic Modalities
SomaScan®Assay v4.1
The SomaScan Platform is a powerful tool with applications in scientific research and health and wellness.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things immuno